WE CAN HELP
Book a FREE consultation  
For a free consultation or assistance, please call 020 7730 6666

Browse by Category

Bimatoprost Scalp Hair Loss Treatment Delayed

lumigan-by-allerganA mid stage trial of Allergan’s proposed hair loss treatment Bimatoprost Scalp has failed to provide sufficient efficacy to proceed to a late stage study, and the company, who also produce Botox, said it would be extending the mid-stage of the development programme. The news will undoubtedly disappoint  those hoping that Bimatoprost would be a viable cure for baldness.

Bimatoprost is a key ingredient in Lumigan eye drops, which are used to treat Glaucoma. The drug has also become known for stimulating eyelash growth, and Allergan had hoped that the drug could be used to produce similar results on thinning areas of the scalp.

Bimatoprost For Balding?

Early stage trials seemed promising: when living scalp tissue was treated with the drug, hair follicles grew a third more than ones without the treatment in a space of just nine days. At the time Dr Elena Koleva, Dermatologist at The Belgravia Centre commented: “If this particular study is accurate then we could have a new effective treatment available in the next few years, but this depends on a number of things including dose and user tolerance when the product is applied topically. I do however wonder if this product would be more effective than the treatments that are already available such as minoxidil or finasteride, which are themselves very effective hair loss treatments.”

For those who don’t fancy the wait for Bimatoprost to possibly become available as a topical hair loss treatment, they could begin a hair loss treatment plan that includes the two medications that the MHRA and the FDA (the UK and US medical regulatory bodies) have licensed or approved for treatment.

Don’t Wait For Hair Loss Treatment

The first proven medication Propecia (which contains finasteride) works by blocking DHT, the androgen hormone that causes male pattern hair loss. DHT makes hair follicles atop the scalp shrink, leading them to produce weak, unhealthy hair. Propecia is great for treating an all over thinning of the top of the head, including a thinning crown.

The second proven medication is minoxidil. Unlike Propecia, which comes in a set daily dose, minoxidil is dose dependent, and your optimum combined daily minoxidil dose can be determined for you by a dedicated hair loss specialist. Minoxidil is applied directly to the areas of thinning on the scalp, and our unique high strength minoxidil cream has shown great results, particularly when treating a stubborn receding hairline.

This combined treatment approach has achieved consistently strong results for our patients and their before and during treatment photographs can be viewed on our success story blog. The two proven medications are combined with a variety of hair growth boosters, which range from added ingredients for our minoxidil formulations that appear to block DHT when applied locally, to our nutritional supplement Hair Vitalics and the FDA cleared LaserComb.

Belgravia offer free consultations to anyone who wants to treat their hair loss. To arrange your no obligation visit to either of our London clinics, contact us. Alternatively, if you’re unable to visit London, an online diagnostic form will give your hair loss specialist everything they need to know in order to diagnose you and recommend a course of treatment.

The Belgravia Centre—————————————————————————————————–

The Belgravia Centre is the leader in hair loss treatment in the UK, with two clinics based in Central London. We offer clinically proven treatments for hair loss, as part of comprehensive treatment programmes offered by our hair loss specialists. Our in-house pharmacies produce high-strength medications for hair loss that contain medically proven ingredients and are available at no other clinic worldwide. Treatment programmes are available by visiting the centres or for home-use, anywhere in the UK or the rest of the world. View our hair loss success stories, which are the largest collection of such success stories in the world and demonstrate the levels of hair regrowth that so many of Belgravia’s patients achieve. You can also phone 0800 077 6666 for our hair loss helpline or to arrange a free consultation.

Share this article

1 Comment

28th May, 2016 at 11:13 am

aliza

Great explanation about hair loss as well as growth. I think though you can’t control most of factors associated with hair loss but one thing which you can certainly do is using a good hair care.

Comment on this article

* required field

Will not be published

Online Consultation

Submit an instant online consultation so that one of Belgravia’s hair loss specialists can diagnose your condition and recommend an effective course of treatment, wherever you live.

28 Jul

FDA Safety Alert for WEN Cleansing Conditioner After Hair Loss Claims

The FDA – America’s equivalent of the UK’s medical licensing body, the MHRA – has taken the unusual step of issuing a safety alert in relation to a product after it received over 100 complaints of it causing hair loss. Accusations made in the 127 reports submitted directly to the FDA – the most ever received for […]

Read full article »
28 Jul

‘I Have a High Forehead and Thinning Hair’

Name: Danraj Question: Hi, I’m 15 and have noticed my hair thinning and I have a very high forehead. It almost seems as if my hair is missing from the front when I pretend to do a man bun style. Even to quiff my hair it looks like there’s no hair at the start of my hairline. […]

Read full article »
27 Jul

Success Story Alert! New Female Hair Loss Treatment Entry

A new entry has just been added to Belgravia’s women’s hair loss treatment Success Stories gallery. This client has two separate conditions – Chronic Telogen Effluvium and Female Pattern Hair Loss which are being treated simultaneously, thanks to a personalised treatment plan, based around a high strength minoxidil product available from Belgravia, as devised by her dedicated hair loss specialist. Find out what this client […]

Read full article »